Browsing articles in "Sexual Disorder"


Bremelanotide Approved to Treat Hypoactive Sexual Desire Disorder
July 6, 2019   

The U.S. Food and Drug Administration approved bremelanotide to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. Bremelanotide, a melanocortin 4 receptor agonist, is...
 Continue reading
August News and New Research
August 1, 2015   

Flibanserin approved for hypoactive sexual desire disorder, childhood poverty linked to changes in structural brain development, no improvement in controlled trial of DBS for severe depression, and other news.
 Continue reading (Members only)
June News and New Research
June 1, 2015   

LAI risperidone superior to oral risperidone in first-episode psychosis, Daytrana patch may cause permanent skin color loss, depression as a prodromal symptom of Parkinson's disease, and other news.
 Continue reading (Members only)
Top of Page